Navigation Links
Blood Gas Analysis: The Pros and Cons of Point-Of-Care Testing

torians, and to ensure that they are met. Additionally, non-laboratorian staff trained on POCT methods must be monitored following the trainings in order to insure their competency with the tests. Training a diverse non-laboratorian staff (including MDs, RNs and RTs) across multiple shifts, instruments, methods, and then monitoring their competency over time is a formidable task which increases with each test introduced and with department size. It is easier to decentralize the test itself than it is to decentralize the specialized laboratory knowledge and training that goes with each test.

Lack of adequate documentation may be considered another drawback to POCT. Results from POCT devices usually appear on a screen with temporary printouts available. Those results may get mishandled or misplaced and never find their way into the patient's permanent medical record. This lack of documentation may also have an affect on potential reimbursement issues.

As health-care providers must consider each advantage and disadvantage to POCT, its technology continues to develop. The analyzers are getting faster, smaller, easier to use, and show the ability to perform accurate testing with smaller blood samples. Radiometer America, Westlake, OH, manufactures one such model, called the 1st automatic blood gas analysis system. The system combines instruments, samplers and information technology to reduce the steps in the analytical process, improve patient and operator safety, and minimize errors. It consists of the safePICO pre-barcoded arterial sampler that helps to remove air bubbles and avoid contact with patient blood while reducing the risk of needlesticks with an onboard safety device; FLEXLINK software to help ensure correct sample, patient, and operator identification; and the FLEXQ module on the ABL800 FLEX analyzer to help reduce errors through automatic identification and mixing of samples.

Abbott Laboratories, Abbott Park, IL, produces the widel
'"/>




Page: 1 2 3 4

Related medicine technology :

1. Rapid Whole Blood Testing for Infectious Mononucleosis Antibodies
2. PSA TestingHow Much is Too Much?
3. Hemoglobin Testing at the Point of Care
4. Testing for Human Papillomavirus
5. Rapid HIV Testing Increases Possibility of Treatment
6. Near-Patient Testing: The Advantages of C-Reactive Protein in Hematological Testing
Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Blood Gas Analysis The Pros and Cons Point Care Testing
(Date:5/8/2008)...irstCall/ -- AstraZeneca (NYSE:,AZN) today announc...cation,(sNDA) to the U.S. Food and Drug Administra...e) Extended-Release Tablets to seek approval for t..., including maintenance of,antianxiety effect. It ...atypical antipsychotic medicine in GAD. The submis...
(Date:5/8/2008)... -- Go Healthy (Pink Sheets: GOHE),announces the i...rade (R),in three medical settings with an expecte...ers around the country. Dr. William Bryan of the S... in the Texas Medical Center,will coordinate one c...sician for the Houston Astros and the former Medic...
(Date:5/7/2008)...nduction Dosing Regimen, SEATTLE, May 7 /PRNewswi...daq: TRBN ) today announced that its partner, Wye...E ), has commenced patient dosing in the next,Phas...eumatoid arthritis,(RA). In collaboration with Tru... SBI-087 and other CD20-directed products., The r...
(Date:5/7/2008)...ll/ -- Shire plc (LSE: SHP,Nasdaq: SHPGY), the gl...nounced findings from a new data analysis that was...AYTRANA(TM) (methylphenidate transdermal,system) b...ntion Deficit,Hyperactivity Disorder (ADHD). The f... has an established safety profile and effectively...
Breaking Medicine Technology:AstraZeneca Submits sNDA for SEROQUEL XR(TM) for the Treatment of Generalized Anxiety Disorder - a First for the Atypical Antipsychotic Class of Medicines 2AstraZeneca Submits sNDA for SEROQUEL XR(TM) for the Treatment of Generalized Anxiety Disorder - a First for the Atypical Antipsychotic Class of Medicines 3AstraZeneca Submits sNDA for SEROQUEL XR(TM) for the Treatment of Generalized Anxiety Disorder - a First for the Atypical Antipsychotic Class of Medicines 4AstraZeneca Submits sNDA for SEROQUEL XR(TM) for the Treatment of Generalized Anxiety Disorder - a First for the Atypical Antipsychotic Class of Medicines 5AstraZeneca Submits sNDA for SEROQUEL XR(TM) for the Treatment of Generalized Anxiety Disorder - a First for the Atypical Antipsychotic Class of Medicines 6AstraZeneca Submits sNDA for SEROQUEL XR(TM) for the Treatment of Generalized Anxiety Disorder - a First for the Atypical Antipsychotic Class of Medicines 7AstraZeneca Submits sNDA for SEROQUEL XR(TM) for the Treatment of Generalized Anxiety Disorder - a First for the Atypical Antipsychotic Class of Medicines 8Go Healthy Initiates Additional Clinical Tests on Cholesterade 2Trubion Announces Initiation of Phase 2b Study of TRU-015 for the Treatment of Rheumatoid Arthritis 2Trubion Announces Initiation of Phase 2b Study of TRU-015 for the Treatment of Rheumatoid Arthritis 3Trubion Announces Initiation of Phase 2b Study of TRU-015 for the Treatment of Rheumatoid Arthritis 4New Analysis in Boys and Girls Shows the ADHD Patch, DAYTRANA(TM) (methylphenidate transdermal system), Offered ADHD Symptom Control for 12 Months 2New Analysis in Boys and Girls Shows the ADHD Patch, DAYTRANA(TM) (methylphenidate transdermal system), Offered ADHD Symptom Control for 12 Months 3New Analysis in Boys and Girls Shows the ADHD Patch, DAYTRANA(TM) (methylphenidate transdermal system), Offered ADHD Symptom Control for 12 Months 4New Analysis in Boys and Girls Shows the ADHD Patch, DAYTRANA(TM) (methylphenidate transdermal system), Offered ADHD Symptom Control for 12 Months 5New Analysis in Boys and Girls Shows the ADHD Patch, DAYTRANA(TM) (methylphenidate transdermal system), Offered ADHD Symptom Control for 12 Months 6New Analysis in Boys and Girls Shows the ADHD Patch, DAYTRANA(TM) (methylphenidate transdermal system), Offered ADHD Symptom Control for 12 Months 7Enrollment of Women in Cardiovascular Trials Fails to Meet Current Federal Mandates 767 1Enrollment of Women in Cardiovascular Trials Fails to Meet Current Federal Mandates 767 2Hemoglobin uncovered 1126 1Hemoglobin uncovered 1126 2Ripe fruit preferred 1124 1Ripe fruit preferred 1124 2Virginia Commonwealth University to Study Genomics Based Diagnostic Test 3A 5625 1Virginia Commonwealth University to Study Genomics Based Diagnostic Test 3A 5625 2Virginia Commonwealth University to Study Genomics Based Diagnostic Test 3A 5625 3Virginia Commonwealth University to Study Genomics Based Diagnostic Test 3A 5625 4
...stCall/ -- Vanda,Pharmaceuticals Inc. announced to...Sleep Disorders and Research Center in Detroit, MI...e III clinical,trial results for VEC-162, Vanda,s ...SLEEP 2007, the 21st annual meeting of the,Associa...nda presentation will take place at the Convention...
...tion during the,early post-operative period compar...tion in nausea in the female,patient population co...- CeNeS Pharmaceuticals plc (AIM:,CEN), the Cambri...itional data from post-hoc analysis of the recent ...onide) in over 500 patients,with post-operative pa...
Other Medicine Technology:Vanda Pharmaceuticals To Present Data on VEC-162 at SLEEP 2007, the,Annual Meeting of the Associated Professional Sleep Societies 2Further Statistical Analysis of the Recent Phase III trial on Lead,Product M6G Shows Additional Benefits 2Further Statistical Analysis of the Recent Phase III trial on Lead,Product M6G Shows Additional Benefits 3Further Statistical Analysis of the Recent Phase III trial on Lead,Product M6G Shows Additional Benefits 4Further Statistical Analysis of the Recent Phase III trial on Lead,Product M6G Shows Additional Benefits 5Further Statistical Analysis of the Recent Phase III trial on Lead,Product M6G Shows Additional Benefits 6Further Statistical Analysis of the Recent Phase III trial on Lead,Product M6G Shows Additional Benefits 7
(Date:5/12/2008)... are being urged to think before they drink as par...binge drinking habits. , A team of health psycho...scover whether using the workplace to supply infor... asking employees for a small commitment to reduci... change peoples binge drinking behaviour in the lo...
(Date:5/12/2008)...ted gene has been discovered as the key behind epi...anks to new research at Adelaides Womens & Childre...lia. , The world-first discovery, published toda...y the bad gene, only women are affected. , The r...ciate Professor Jozef Gecz from the Department of ...
(Date:5/12/2008)...OUTH MEETING, Pa., May 12 /Xinhua-PRNewswire-First...,BMP Sunstone, or the ,Company,),one of China,...l companies,today announced that it plans to rele..., May 19, 2008, before the market opens., The Com...:00 am ET to,discuss fiscal first quarter 2008 res...
(Date:5/12/2008)...I PROVINCE, China, May 12 /Xinhua-PRNewswire-First...Board: BPMA), a China-based,pharmaceutical company...e,therapy medicine for the treatment of cancer, an...today announced that it has appointed Jun Tang to,...r. Tang has over a decade of experience in corpora...
Breaking Medicine News(10 mins):Health News:Think before you drink, says university research 2Health News:Mutant gene causes epilepsy, intellectual disability in women 2Health News:BMP Sunstone to Report First Quarter 2008 Financial Results 2Health News:Benda Pharmaceutical Appoints Jun Tang to Board of Directors 2Health News:Benda Pharmaceutical Appoints Jun Tang to Board of Directors 3
...oman’s reproductive years, usually occurs around a...xperience //early menopause. Early menopause can b...ealth problems, including osteoporosis and cardiov...of Mayo Clinic Women’s HealthSource describes type...
...fits of mammogram screenings because the results a... study by //Yale Public Health researchers in the ... To help reduce death and disability from breast ...of cancer death in American women, current guideli...
...rsity scientists led by Thomas Carpenter, findings...lements for girls, as their effects// would be see...sts carried out a trial on 120 girls aged 8 to 14 ...ium supplements of 300 mg dose and others on a pla...
...ore dispensaries by 2010 to provide better healthc... said Thursday.// She said 365 dispensaries were ... would be set up soon to "enable the common men av...heir doorsteps". The chief minister said her gov...
Other Medicine News:Health News:Inadequate Communication Reduces Benefits of Mammogram Screening for Black Women 2
... national reference laboratory and a worldwide lea...ent. ARUP offers an extensive test menu of highly ...natomic pathology. Owned by the University of Utah...f of the nation's university teaching hospitals an...
... national reference laboratory and a worldwide lea...ent. ARUP offers an extensive test menu of highly ...natomic pathology. Owned by the University of Utah...f of the nation's university teaching hospitals an...
... national reference laboratory and a worldwide lea...ent. ARUP offers an extensive test menu of highly ...natomic pathology. Owned by the University of Utah...f of the nation's university teaching hospitals an...
... national reference laboratory and a worldwide lea...ent. ARUP offers an extensive test menu of highly ...natomic pathology. Owned by the University of Utah...f of the nation's university teaching hospitals an...
Medicine Products: